L

Eli Lilly & Co.

XNYS · Laboratory Analytical Instruments · S&P 500

$1,146.90

-$32.75 (-2.78%) today

Open $1,179.65 High $1,187.12 Low $1,144.43 Vol 2,644K Avg $1,157.63

Related Stocks

Find similar stocks by technical condition — S&P 500 universe

Symbol Company Name Exchange Currency Category
PMN ProMIS Neurosciences Inc. Common Shares (ON) XNAS USD PHARMACEUTICAL PREPARATIONS
EDSA Edesa Biotech, Inc. Common Shares XNAS USD PHARMACEUTICAL PREPARATIONS
KALV KalVista Pharmaceuticals, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS
GERN Geron Corp XNAS USD PHARMACEUTICAL PREPARATIONS
TELO Telomir Pharmaceuticals, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS
XNCR Xencor, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
INO Inovio Pharmaceuticals, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
AMPH Amphastar Pharmaceuticals, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
AXSM Axsome Therapeutics, Inc XNAS USD PHARMACEUTICAL PREPARATIONS
ANNX Annexon, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS

52-week price range

$623.78 $1,249.45

Price is 83.9% above its 52-week low and 8.2% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

  • Primary Exchange: XNAS
  • Market Cap: 775675447063.4
  • Address:
  • Category: PHARMACEUTICAL PREPARATIONS
  • Total Employees: 50000
  • Listing Date: 1970-07-09